Ascendis Pharma A/S Gains On Change In Fair Value Of Derivatives
Ascendis Pharma A/S (ASND) reported Gains On Change In Fair Value Of Derivatives of EUR 14.65 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-02-07.
Discontinued › Income Statement › Other Income
ifrs-full:GainsOnChangeInFairValueOfDerivatives · last filed 2024-02-07
| Period end | Gains On Change In Fair Value Of Derivatives 12 month |
|---|---|
| 2023-12-31 | 14.65M EUR 20-F · filed 2024-02-07 |